-
Recent Posts
- Consumer Financial Protection Bureau Update
- In re Toyota Motor Corporation Securities Litigation
- Sarbanes-Oxley Whistleblower Protections Limited By Divided Panel Of First Circuit Court Of Appeals
- SEC Expands Exchange-Traded Fund Investigation
- The Securities Act Of 1933 And Foreign Securities Transactions – Morrison Strikes Again
Archives
Subscribe to RSS feeds
Monthly Archives: July 2011
Class Action Against Atheros Communications, Inc.
A securities class action was filed in the United States District Court for the Northern District of California on behalf of a class consisting of all purchasers of Atheros Communications, Inc. (“Atheros” or the “Company”) securities during the time period … Continue reading
Posted in Uncategorized
Leave a comment
Class Action Against Magnum d’Or Resources, Inc.
A securities class action was filed in the United States District Court for the Southern District of Florida on behalf of a class consisting of all purchasers of Magnum d’Or Resources, Inc. (“Magnum” or the “Company”) securities during the time … Continue reading
Posted in Uncategorized
Leave a comment
Class Action Against China Medicine Corporation
A securities class action was filed in the United States District Court for the Central District of California on behalf of a class consisting of all purchasers of China Medicine Corporation (“China Medicine” or the “Company”) securities during the time … Continue reading
Posted in Uncategorized
Leave a comment
Securities Class Action Against Ebix, Inc.
A securities class action was filed in the United States District Court for the Southern District of New York on behalf of a class consisting of all purchasers of Ebix, Inc. (“Ebix” or the “Company”) securities during the time period … Continue reading
Posted in Uncategorized
Leave a comment
Class Action Against BioMimetic Therapeutics, Inc.
A securities class action was filed in the United States District Court for the Middle District of Tennessee on behalf of a class consisting of all purchasers of BioMimetic Therapeutics, Inc. (“BMTI,” “BioMimetic” or the “Company”) securities during the time … Continue reading
Posted in Uncategorized
Leave a comment
